Skip to content

Microneedle Patch With Botulinum Toxin in Management of Enlarged Facial Pores

The Efficacy of Microneedle Patch With Botulinum Toxin in Management of Enlarged Facial Pores Compared to Intradermal Botulinum Toxin

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06293755
Enrollment
16
Registered
2024-03-05
Start date
2024-02-28
Completion date
2024-06-25
Last updated
2024-03-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Enlarged Pores

Brief summary

The purpose of this study is to assess the efficacy and safety of microneedle patch with botulinum toxin for improving enlarged pores.

Interventions

with 20 units botulinum toxin

with 20 units botulinum toxin

Sponsors

Dhurakij Pundit University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* At least 18 years old and concerned about enlarged pores * Have pore size 0.3-0.6 mm * Have pore parameter in each other side of faces not different more than 5%

Exclusion criteria

* Any neuromuscular condition * Pregnancy or breast feeding * History of allergy : Botulinum toxin, topical anesthesia * History of keloid or hypertrophic scar * History of coagulation or receiving medication that causes coagulation disorder * Using drugs that have interaction with Botulinum toxin * Using topical medication that improves enlarged pores in 1 month * Taking medication that improves enlarged pores in 1 month * Receiving the laser/treatment/chemical peeling in 6 months

Design outcomes

Primary

MeasureTime frameDescription
Change from baseline of enlarged pores as measured by VISIA (pores parameter) and using pore scorePost-intervention, week 4 and week 16the used pore scores, patients with visible pores took the score 1, and those with enlarged pores took 2. When black heads were embedded on facial pores the score was 3. The scores were assessed by 2 investigators who were blinded to the treatment used on each side.

Countries

Thailand

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026